DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION

Aehr Test Systems, Inc.

NasdaqCM:AEHR Stock Report

Market Cap: US$3.1b

  • Company Overview
  • Valuation
  • Future Growth
  • Past Performance
  • Financial Health
  • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Aehr Test Systems Future Growth

Future criteria checks 5/6

Aehr Test Systems is forecast to grow earnings and revenue by 104.5% and 27.7% per annum respectively. EPS is expected to grow by 39.2% per annum. Return on equity is forecast to be 11.5% in 3 years.

Key information

104.5%

Earnings growth rate

39.21%

EPS growth rate

Semiconductor earnings growth30.5%
Revenue growth rate27.7%
Future return on equity11.45%
Analyst coverage

Low

Last updated10 Sep 2026

Recent future growth updates

Recent updates

User avatar
New Narrative • Sep 12

AI Data Center And Silicon Photonics Demand Will Drive Long-Term Upside Potential

Catalysts About Aehr Test Systems Aehr Test Systems supplies wafer level and package level burn in and test equipment used to improve semiconductor device reliability. What are the underlying business or industry changes driving this perspective?
User avatar
New Narrative • Aug 29

AI Test Demand Will Face Customer And Supply Risks Yet Ultimately Reward Patience

Catalysts About Aehr Test Systems Aehr Test Systems supplies test and burn in equipment for semiconductor devices used in AI processors, data centers, power electronics and memory. What are the underlying business or industry changes driving this perspective?
User avatar
New Narrative • Aug 14

AI Data Center Demand And Silicon Photonics Will Support Long-Term Prospects Here

Catalysts About Aehr Test Systems Aehr Test Systems supplies wafer-level and package-level burn-in and test equipment used to screen and qualify semiconductors for reliability. What are the underlying business or industry changes driving this perspective?
Seeking Alpha • Jul 18

Aehr Test Systems: Still Some Worry About The Blue-Sky Bull Case

Summary Aehr Test Systems, Inc. has shifted its narrative from an EV supplier to a diversified AI-driven growth story. FY27 guidance projects 160–200% revenue growth, driven by AI accelerators, CPUs, and network processors, but customer concentration remains a risk. AEHR stock's valuation is high at ~18x FY27 revenue and ~45x gross profit, yet comparable to other AI winners if growth persists. Key concerns include reliance on a lead customer and uncertainty whether wafer-level test and burn-in, or WLTBI, becomes an industry standard. Read the full article on Seeking Alpha
Analysis Article • Jun 19

Aehr Test Systems (AEHR) Stock Could Be 531.1% Overvalued After AI Data Center Order

Aehr Test Systems (AEHR) is back in focus after securing a follow-on production order for its fully automated FOX-XP wafer-level burn-in system from a leading networking customer that is expanding hyperscale and AI-driven data centers. See our latest analysis for Aehr Test Systems. The latest FOX-XP order lands as Aehr Test Systems rides very strong momentum, with a 30-day share price return of 42.11% and a 90-day share price return of 234.01%. The one-year total shareholder return is...
User avatar
New Narrative • Apr 21

AEHR Insiders Cashed Out $25.9M After Years of Shareholder Dilution

Heavy insider selling, repeated dilution, and weakening fundamentals raise serious questions about shareholder alignment Aehr Test Systems (NASDAQ: AEHR) has often been presented as a high-growth semiconductor equipment story tied to silicon carbide, EV power devices, and emerging AI infrastructure demand. But behind the narrative lies a more uncomfortable reality for shareholders: years of dilution followed by a major insider cash-out during a sharp stock rally.
Analysis Article • Jan 17

Aehr Test Systems, Inc.'s (NASDAQ:AEHR) 34% Price Boost Is Out Of Tune With Revenues

Aehr Test Systems, Inc. ( NASDAQ:AEHR ) shareholders would be excited to see that the share price has had a great...
Analysis Article • Nov 20

Aehr Test Systems, Inc. (NASDAQ:AEHR) Shares May Have Slumped 31% But Getting In Cheap Is Still Unlikely

Aehr Test Systems, Inc. ( NASDAQ:AEHR ) shares have retraced a considerable 31% in the last month, reversing a fair...
Analysis Article • Aug 28

There's Reason For Concern Over Aehr Test Systems, Inc.'s (NASDAQ:AEHR) Massive 29% Price Jump

Despite an already strong run, Aehr Test Systems, Inc. ( NASDAQ:AEHR ) shares have been powering on, with a gain of 29...
Analysis Article • Aug 20

Calculating The Intrinsic Value Of Aehr Test Systems, Inc. (NASDAQ:AEHR)

NasdaqCM:AEHR 1 Year Share Price vs Fair Value Explore Aehr Test Systems's Fair Values from the Community and select...
Analysis Article • Jul 09

Further Upside For Aehr Test Systems, Inc. (NASDAQ:AEHR) Shares Could Introduce Price Risks After 34% Bounce

Aehr Test Systems, Inc. ( NASDAQ:AEHR ) shares have continued their recent momentum with a 34% gain in the last month...
User avatar
New Narrative • Jun 27

Aehr Test Systems will leverage AI for significant growth potential

There are a couple of reasons that I like this stock, but I still need to look more into it, however I do currently own some shares. As of right now AEHR is in a good position with AI about to explode
Seeking Alpha • Mar 27

Aehr Test Systems: An Earnings Show-Me Story, Optimistic For A Turnaround

Summary Aehr Test Systems has faced significant challenges, including weak silicon carbide sales and intense competition, but remains a buy due to low valuation and potential EPS growth. Despite a sharp underperformance since early 2024 and a disappointing Q2, AEHR is diversifying revenue streams and expanding into AI processors, which could drive future growth. Key risks include ongoing supply chain issues, competition, and uncertainties in the silicon carbide market, but recent positive economic data from China offers hope for a turnaround. Technically, AEHR faces resistance at $10 and bearish indicators, but a bullish response to earnings could target a long-term upside gap around $16. Read the full article on Seeking Alpha
Analysis Article • Feb 06

Not Many Are Piling Into Aehr Test Systems, Inc. (NASDAQ:AEHR) Stock Yet As It Plummets 34%

Aehr Test Systems, Inc. ( NASDAQ:AEHR ) shareholders won't be pleased to see that the share price has had a very rough...
Seeking Alpha • Jan 16

Aehr Test Systems: Selloff Was Justified But I'm Still Cautiously Optimistic (Rating Downgrade)

Summary Aehr Test Systems' competitive advantage lies in its best-in-class test systems used for both EV and AI chips. The company's poor 2024 performance was due to an EV slowdown and reduced capex from its largest customer. Recent orders from AI and GaN customers signal strong growth for the second half of 2025 and increasing trust in Aehr's technology. Read the full article on Seeking Alpha
Seeking Alpha • Dec 17

Aehr Test Systems: With A Turnaround In Sight, It's High On My Watchlist To Build A Proper Position

Summary Aehr Test Systems' share price dropped 30% since the last update but shows potential recovery, driven by positive news on diversification and SiC segment outlook. Latest earnings beat expectations with $13M in revenue, mainly from SiC; diversification into GaN and AI segments is progressing. Secured initial AI orders, boosting stock by 21%; diversification could bring significant revenue growth, but competition may arise. Despite positive signs, I remain cautious due to SiC market recovery uncertainty and macroeconomic factors, holding off on a buy rating for now. Read the full article on Seeking Alpha
Analysis Article • Dec 17

Improved Earnings Required Before Aehr Test Systems, Inc. (NASDAQ:AEHR) Stock's 34% Jump Looks Justified

Aehr Test Systems, Inc. ( NASDAQ:AEHR ) shares have had a really impressive month, gaining 34% after a shaky period...
Analysis Article • Oct 23

Aehr Test Systems' (NASDAQ:AEHR) Earnings Might Not Be As Promising As They Seem

Aehr Test Systems, Inc.'s ( NASDAQ:AEHR ) stock performed strongly after the recent earnings report. Investors should...
Analysis Article • Oct 19

Aehr Test Systems, Inc.'s (NASDAQ:AEHR) Shares Bounce 30% But Its Business Still Trails The Market

Aehr Test Systems, Inc. ( NASDAQ:AEHR ) shareholders are no doubt pleased to see that the share price has bounced 30...
Seeking Alpha • Oct 11

Aehr Test Systems: Enthusiastic Management But Weak Near-Term Prospects, Hold

Summary Shares of wafer level test and burn-in system supplier Aehr Test Systems rallied after the close of Thursday's regular session as investors cheered better-than-expected Q1/FY2025 results. Results and backlog benefited from the recent acquisition of Incal Technologies. As usual, management remained enthusiastic about the company's diversification into new markets, including AI. However, expansion into new markets won't offset persistent weakness in the core silicon carbide system business anytime soon. While market participants are likely to celebrate perceived AI market prospects in the near-term, persistent weakness in the company's core business is keeping me sidelined for now. Read the full article on Seeking Alpha
Analysis Article • Sep 07

Aehr Test Systems (NASDAQ:AEHR) Is Experiencing Growth In Returns On Capital

To find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is...

Earnings and Revenue Growth Forecasts

NasdaqCM:AEHR - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/2029215N/A10181
6/30/20282124325342
6/30/202714119-4182
5/29/202650-7-5-3N/A
2/27/202645-11-12-7N/A
11/28/202553-9-12-5N/A
8/29/202557-7-16-10N/A
5/30/202559-4-12-7N/A
2/28/20256123-6-4N/A
11/29/20245122-6-5N/A
8/30/2024592900N/A
5/31/2024663312N/A
2/29/2024721556N/A
11/30/2023822168N/A
8/31/2023751978N/A
5/31/20236515910N/A
2/28/2023631433N/A
11/30/2022611212N/A
8/31/202256955N/A
5/31/202251912N/A
2/28/202238422N/A
11/30/202128155N/A
8/31/202120-1-2-1N/A
5/31/202117-2-3-3N/A
2/28/202113-5-4-4N/A
11/30/202014-4-4-4N/A
8/31/202019-2-1-1N/A
5/31/202022-3-2-2N/A
2/29/2020260N/A-1N/A
11/30/201923-3N/A-3N/A
8/31/201922-4N/A-5N/A
5/31/201921-5N/A-6N/A
2/28/201921-5N/A-3N/A
11/30/201825-2N/A-2N/A
8/31/201827-1N/A2N/A
5/31/2018301N/A-1N/A
2/28/2018290N/A-3N/A
11/30/201724-3N/A-5N/A
8/31/201721-5N/A-10N/A
5/31/201719-6N/A-4N/A
2/28/201714-8N/A-6N/A
11/30/201613-8N/A-4N/A
8/31/201613-8N/A-3N/A
5/31/201615-7N/A-6N/A
2/29/201615-6N/A-5N/A
11/30/201515-4N/A-5N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: AEHR is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (3.7%).

Earnings vs Market: AEHR is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: AEHR is expected to become profitable in the next 3 years.

Revenue vs Market: AEHR's revenue (27.7% per year) is forecast to grow faster than the US market (13.4% per year).

High Growth Revenue: AEHR's revenue (27.7% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: AEHR's Return on Equity is forecast to be low in 3 years time (11.5%).


Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/13 02:25
End of Day Share Price 2026/09/11 00:00
Earnings2026/05/29
Annual Earnings2026/05/29

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Aehr Test Systems, Inc. is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Christian SchwabCraig-Hallum Capital Group LLC
Egor TolmachevFreedom Broker
Danial YermakhanFreedom Broker

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide